Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 67

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 67
---
 set forth on . For so long as any Preferred Shares are outstanding, the Company will not
issue or amend the terms of any securities or Common Shares Equivalents or of any agreement outstanding or in effect as of the date of
this Agreement pursuant to which same were or may be acquired without the consent of a Majority in Interest. The restrictions and limitations
in this Section 4.13 are in addition to and shall apply whether or not a Purchaser exercises its rights pursuant to Section 4.17 and Section
4.23. The restrictions and limitations in this Section shall not be applicable to Exempt Issuances, but a Variable Rate Transaction shall
not be deemed an Exempt Issuance.

4.14 . No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of any Transaction Document unless the same consideration is also offered on a
ratable basis to all of the Purchasers or their successors. For clarification purposes, this provision constitutes a separate right granted
to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise. The foregoing does not constitute a waiver or forbearance of any right adhering to each individual
Purchaser.

4.15 .
For so long as the Shares are outstanding, the Company shall not undertake a reverse or forward stock split or reclassification of the
Common Shares without five (5) days prior written notice to the Purchasers. In no event will the Company at any time Securities are outstanding
directly or indirectly increase the par value of the Common Shares.

<div align='center'>35</div>

4.16 . The Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant
hereby that it will not engage in effecting transactions in any securities of the Company, (ii) no Purchaser shall be restricted or prohibited
from effecting any transactions in any securities of the Company in accordance with Applicable Law, and (iii) no Purchaser shall have
any duty of confidentiality to the Company or its Subsidiaries. Except as described in this Section 4.16, the Company acknowledges that
no Purchaser owes any confidentiality obligation to the Company or